Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
Release Notes Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: TMP019
MIFTS: 38

Temporomandibular Joint Anomaly

Categories: Gastrointestinal diseases, Mental diseases, Muscle diseases, Oral diseases, Rare diseases
Data Licensing
For inquiries, contact:
[email protected]
Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Temporomandibular Joint Anomaly

About this section

MalaCards integrated aliases for Temporomandibular Joint Anomaly:

Name: Temporomandibular Joint Anomaly 58
Temporomandibular Joint Dysfunction 75 41 33
Tmjpds - [temporomandibular Joint Pain Dysfunction Syndrome] 33
Temporomandibular Joint-Pain-Dysfunction Syndrome 33
Tmj - [temporomandibular Joint Disorder] Syndrome 33
Temporomandibular Developmental Disorder of Jaw 33
Tmj - [temporomandibular Joint] Dysfunction 33
Tmj - [temporomandibular Joint] Disorder 33
Temporomandibular Joint Disorder 16
Temporomandibular Joint Syndrome 33
Temporomandibular Joint Disease 33
Temporomandibular Jaw Disorder 33
Temporomandibular Dysfunction 33
Mandibular Dysfunction Nos 33

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Gastrointestinal diseases Muscle diseases Oral diseases Mental diseases
See all MalaCards categories (disease lists)
ICD10: 31
ICD11: 33


External Ids:

ICD10 31 K07.6
Orphanet 58 ORPHA210581
ICD11 33 897101649
Sources

Summaries for Temporomandibular Joint Anomaly

About this section

MedlinePlus: 41 The temporomandibular joint (TMJ) connects your jaw to the side of your head. When it works well, it enables you to talk, chew, and yawn. For people with TMJ dysfunction, problems with the joint and muscles around it may cause : Pain that travels through the face, jaw, or neck Stiff jaw muscles Limited movement or locking of the jaw Painful clicking or popping in the jaw A change in the way the upper and lower teeth fit together Jaw pain may go away with little or no treatment. Treatment may include simple things you can do yourself, such as eating soft foods or applying ice packs. It may also include pain medicines or devices to insert in your mouth. In very rare cases, you might need surgery. NIH: National Institute of Dental and Craniofacial Research

MalaCards based summary: Temporomandibular Joint Anomaly, also known as temporomandibular joint dysfunction, is related to ankylosis and osteoarthritis. An important gene associated with Temporomandibular Joint Anomaly is COMT (Catechol-O-Methyltransferase), and among its related pathways/superpathways are Vitamin D receptor pathway and Clock-controlled autophagy in bone metabolism. The drugs Diclofenac and Dexamethasone acetate have been mentioned in the context of this disorder. Affiliated tissues include skeletal muscle, tongue and brain.

Wikipedia: 75 Temporomandibular joint dysfunction (TMD, TMJD) is an umbrella term covering pain and dysfunction of the... more...
Sources

Related Diseases for Temporomandibular Joint Anomaly

About this section

Diseases related to Temporomandibular Joint Anomaly via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 189)
# Related Disease Score Top Affiliating Genes
1 ankylosis 29.8 TNFSF11 TNFRSF11B
2 osteoarthritis 29.7 TNFSF11 TNFRSF11B MMP3
3 aortic valve disease 2 29.7 TNFSF11 TNFRSF11B
4 synovitis 29.7 TNFSF11 TNFRSF11B MMP3
5 periodontitis 29.6 TNFSF11 MMP3
6 arthropathy 29.6 TNFSF11 TNFRSF11B MMP3
7 cholesteatoma of middle ear 29.5 TNFSF11 MMP3
8 spondyloarthropathy 1 29.2 TNFSF11 TNFRSF11B MMP3
9 psoriatic arthritis 29.1 TNFSF11 TNFRSF11B MMP3 IL1RAPL2
10 rheumatoid arthritis 28.8 TNFSF11 TNFRSF11B MMP3 IL1RAPL2
11 osteoporosis 28.5 TNFSF11 TNFRSF11B MMP3 IL1RAPL2 COMT
12 fibromyalgia 11.2
13 primary condylar hyperplasia 11.2
14 chronic pain 11.2
15 patulous eustachian tube 11.1
16 headache 10.4
17 bruxism 10.4
18 paine syndrome 10.3
19 whiplash 10.3
20 ehlers-danlos syndrome 10.3
21 myofascial pain syndrome 10.3
22 hypermobile ehlers-danlos syndrome 10.3
23 personality disorder 10.2
24 hemifacial atrophy, progressive 10.1
25 apraxia 10.1
26 glucose intolerance 10.1
27 neuritis 10.1
28 agnosia 10.1
29 herpes simplex 10.1
30 hypoglycemia 10.1
31 migraine with or without aura 1 10.1
32 otitis media 10.1
33 trigeminal neuralgia 10.1
34 orthostatic intolerance 10.1
35 exostosis 10.1
36 acromegaly 10.1
37 neurofibromatosis 10.1
38 meningioma, familial 10.1
39 major depressive disorder 10.1
40 abducens palsy 10.0
41 marfan syndrome 10.0
42 moebius syndrome 10.0
43 myositis 10.0
44 myotonic dystrophy 1 10.0
45 temporal arteritis 10.0
46 suppressor of tumorigenicity 3 10.0
47 masa syndrome 10.0
48 major affective disorder 2 10.0
49 neurofibromatosis-noonan syndrome 10.0
50 anorexia nervosa 10.0

Graphical network of the top 20 diseases related to Temporomandibular Joint Anomaly:



Diseases related to Temporomandibular Joint Anomaly
Sources

Symptoms & Phenotypes for Temporomandibular Joint Anomaly

About this section
Sources

Drugs & Therapeutics for Temporomandibular Joint Anomaly

About this section

Drugs for Temporomandibular Joint Anomaly (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 179)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Diclofenac Approved, Vet_approved Phase 4 15307-86-5, 15307-79-6 3033
2
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3 3680
3
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 3003 5743
4
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
5
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
6
Acetaminophen Approved Phase 4 103-90-2 1983
7
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
8
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
9
Metamizole Approved, Investigational, Withdrawn Phase 4 50567-35-6 3111 522325
10
Clavulanic acid Approved, Vet_approved Phase 4 58001-44-8 5280980
11
Cathine Approved, Experimental, Illicit, Vet_approved, Withdrawn Phase 4 14838-15-4, 492-39-7 131954576 4786 26934
12
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
13
Codeine Approved, Illicit Phase 4 76-57-3, 6854-40-6 5284371 5362471
14
Naproxen Approved, Vet_approved Phase 4 22204-53-1 156391 1302
15
Morphine Approved, Investigational Phase 4 57-27-2 5288826
16
Granisetron Approved, Investigational Phase 4 109889-09-0 3510 5284566
17 Antirheumatic Agents Phase 4
18 Cyclooxygenase Inhibitors Phase 4
19 Anti-Inflammatory Agents, Non-Steroidal Phase 4
20 Analgesics, Non-Narcotic Phase 4
21 Anti-Inflammatory Agents Phase 4
22 Anesthetics Phase 4
23 Antibiotics, Antitubercular Phase 4
24 Anti-Bacterial Agents Phase 4
25 Adjuvants, Immunologic Phase 4
26 Betamethasone-17,21-dipropionate Phase 4
27
Betamethasone Valerate Phase 4 2152-44-5
28
Betamethasone sodium phosphate Phase 4
29
Betamethasone benzoate Phase 4
30 Viscosupplements Phase 4
31 Immunologic Factors Phase 4
32 Protective Agents Phase 4
33 Neurotransmitter Agents Phase 4
34
abobotulinumtoxinA Phase 4
35 Botulinum Toxins, Type A Phase 4
36 Dexketoprofen trometamol Phase 4
37 Antipyretics Phase 4
38 Hypnotics and Sedatives Phase 4
39 Hormones Phase 4
40 Hormone Antagonists Phase 4
41 Gastrointestinal Agents Phase 4
42
incobotulinumtoxinA Phase 4
43 Antineoplastic Agents, Hormonal Phase 4
44 Antiemetics Phase 4
45 glucocorticoids Phase 4
46 Respiratory System Agents Phase 4
47 BB 1101 Phase 4
48 Antitussive Agents Phase 4
49 Chlorpheniramine, phenylpropanolamine drug combination Phase 4
50
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202

Interventional clinical trials:

(show top 50) (show all 299)
# Name Status NCT ID Phase Drugs
1 A Double Blind Randomised Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint Dysfunction Completed NCT01524913 Phase 4 Hyaluronic acid;Corticosteroid;Lactated Ringers
2 Evaluation of the Efficacy of Different Drugs in the Treatment of the Pain in Patients With Temporomandibular Disorder Completed NCT05529290 Phase 4 Dexketoprofen Trometamol + Thiocolchicoside;Dexketoprofen Trometamol + Paracetamol;Dexketoprofen Trometamol (25mg);Paracetamol
3 Hyaluronic Acid Evaluation as Adjuvant to Temporomandibular Joint Arthroscopy in Wilkes Stages Completed NCT04110587 Phase 4 Antibiotic therapy;corticosteroid;Antiinflammatories;Analgesics
4 Comparison of Temporomandibular Joint Arthroscopy With Botulinum Toxin Injection Versus Placebo: a Randomized Clinical Trial Completed NCT04810429 Phase 4 Incobotulinumoxin A
5 Analgesic Efficacy of Naproxen-codeine, Naproxen+Dexamethasone, and Naproxen on Myofascial Pain: A Randomized Double-blind Controlled Trial Completed NCT04066426 Phase 4 naproxen sodium+codeine phosphate, naproxen sodium+dexamethasone, naproxen sodium, paracetamol
6 The Serotonin Receptor Type 3 Antagonist Granisetron as a New Treatment Approach for Patients With Chronic Myofascial Pain in the Orofacial Muscles Completed NCT02230371 Phase 4 Granisetron;Control (placebo)
7 The Efficacy of Occlusal Stabilization Appliance Associated to Counseling in the Management of Myofascial Pain Chronic and in the Improvement of the Quality of Life of Patients With Temporomandibular Disorders Unknown status NCT01544439 Phase 3
8 Effect of Stimulation of the Proprioceptive Trigeminocardiac Reflex Through Medical Device for the Pain of Patients With Temporomandibular Disorders Unknown status NCT02908568 Phase 2, Phase 3
9 Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection: A Randomised Clinical Trial of Efficacy Completed NCT01706172 Phase 2, Phase 3
10 Comparison of a Biofeedback-Based Cognitive Behavioral Treatment and Occlusal Splint Therapy for Temporomandibular Disorders. A Randomized Clinical Trial. Completed NCT00769561 Phase 2, Phase 3
11 Evaluation of Postural Balance in Individuals With Temporomandibular Disorder by Means of Force Platform After Using Occlusal Stabilizer Splint Disorder Completed NCT02251015 Phase 3
12 Comparison of Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles in the Management of Myofascial Pain Disorder: A Randomized Clinical Trial Completed NCT03223298 Phase 3 Botulinum toxin type A;0.9% Sodium Chloride Injection
13 Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With Temporomandibular Disorders: a Randomized, Double-blind Study Completed NCT03994640 Phase 2, Phase 3
14 The Platelet -Rich Plasma in the Therapy of Temporomandibular Disorders Completed NCT03371888 Phase 2, Phase 3
15 Methodology for Developing an Occlusal Appliance With CBD Active Carrier Recruiting NCT04775030 Phase 2, Phase 3 CBD occlusal appliance
16 Assesment of ODF ( Oral Dissolvable Film) With Long-term CBD Release in the Treatment of Temporomandibular Disorders Recruiting NCT05562635 Phase 2, Phase 3
17 A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Temporomandibular Disorders (TMD) Recruiting NCT05262517 Phase 2, Phase 3 Rimegepant;Placebo
18 Assessment of the Effectiveness of Intra-articular Injectable Platelet-rich Fibrin (iPRF) Injections in the Management of Mild and Moderate Degeneration of the Temporomandibular Joints Enrolling by invitation NCT05214924 Phase 2, Phase 3
19 Effectiveness of the Use of Antidepressants in the Treatment of Muscle Type Temporomandibular Disorders Not yet recruiting NCT04777838 Phase 2, Phase 3 Citalopram 10 MG;Amitriptyline
20 Effect of Phototherapy on Pain, Muscles Activity and Joint Mobility in Individuals With Temporomandibular Disorder: A Randomized, Placebo-Controlled and Double-Blind Clinical Trial. Unknown status NCT02018770 Phase 1, Phase 2
21 Effects of Photobiomodulation With Simultaneous Use in a Same LED Device (Red and Infrared) on Clinical Aspects in Individuals With Temporomandibular Dysfunction: Clinical, Randomized, Controlled and Blind Trial. Unknown status NCT03696706 Phase 2
22 Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction (A Randomized Clinical Trial) Unknown status NCT04557878 Phase 2 Hypertonic Dextrose Solution
23 Effect of Noninvasive Neuromodulation on Chronic Pain and Anxiety Levels in Individuals With Temporomandibular Disorders Unknown status NCT03285685 Phase 2
24 Effects of Laser Therapy and LED Therapy on Elderly Individuals With Temporomandibular Disorder: a Randomized, Controlled, Double-blind, Clinical Trial Unknown status NCT03257748 Phase 2
25 Treatment of Temporomandibular Disorder Completed NCT01958879 Phase 2 ringer with corticosteroid;ringer without corticosteroid
26 Randomized, Double Blind, Placebo Controlled Exploratory Study To Assess the Efficacy and Safety of a Triple Combination of Ibuprofen+Mg+Ascorbic Acid for Acute Pain Treatment in Temporomandibular Join Disorder (TMJD) Patients Completed NCT02602483 Phase 1, Phase 2 Ibuprofen;Magnesium;Ascorbic Acid;Placebo
27 A Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Nasal CO2 in the Symptomatic Treatment of Temporomandibular Disorders Completed NCT00484029 Phase 2 Nasal Carbon Dioxide
28 TCM for TMD: A Multi-Site Whole Systems Trial Completed NCT00856167 Phase 2 TCM
29 Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain Completed NCT02794922 Phase 2 Neurovit Forte;Corn Starch
30 Treatment Outcome of Temporomandibular Disorders Via the Clayton Intra-aural Device (CID): A Randomized Clinical Trial Completed NCT00815776 Phase 1, Phase 2
31 Complementary Medicine Approaches to TMD Pain Management Completed NCT00010621 Phase 2
32 Alternative Medicine Approaches for Women With Temporomandibular Disorders Completed NCT00009594 Phase 2
33 The Role of Cytokines as Inflammatory Mediators in Painful Temporomandibular Joints Completed NCT00001955 Phase 2 Etanercept;Celecoxib
34 Basis for an Etiological Diagnosis and Treatment of the Chronic TMD-pain: RCT Study Completed NCT00899717 Phase 1, Phase 2
35 Pain Management in Temporomandibular Joint Disorders Completed NCT00066937 Phase 2 Nortriptyline Oral Capsule;Benztropine Oral Product
36 Effect of COMT (Catecholamine-O-methyltransferase) Genetic Polymorphisms on Response to Propranolol Therapy in Temporomandibular Disorder Completed NCT02437383 Phase 2 Propranolol ER;Placebo
37 Comparative Effectiveness of Photobiomodulation and Manual Therapy Alone or Combined in TMD Patients: a Randomized Clinical Trial Completed NCT03454581 Phase 2
38 Quality of Life, Patient Satisfaction, Quality of Dentures, Masticatory Efficiency, Presence of Temporomandibular Dysfunction and Costs Analysis of Simplified and Conventional Techniques for Complete Denture Fabrication Completed NCT02652403 Phase 2
39 Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint. Recruiting NCT04609748 Phase 2 Cannabidiol Oil;Nimesulide
40 The Effect of Opioid-Free Anesthesia in TMJ Surgery: A Prospective Study Recruiting NCT04724759 Phase 2 Dexmedetomidine / Ketamine / Lidocaine
41 Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments Recruiting NCT03844412 Phase 2 5% lidocaine/5 mg/ml 0.02% estradiol compound cream;Nortriptyline;Placebo cream;Placebo pill
42 A Randomized, Double Blind, Placebo-Controlled Single Center Phase 2 Pilot Study to Assess the Safety and Efficacy of Off-label Subcutaneous Administration of Erenumab-aooe in Patients With Temporomandibular Disorder Recruiting NCT04884763 Phase 2 Erenumab-aooe (EREN) 140 mg s.c. administered every four weeks for a total of five treatments;Placebo (EREN-P) s.c. administered every four weeks for a total of five treatments
43 Erenumab as a Therapeutic Approach for the Management of Painful Chronic Temporomandibular Disorders (TMD) Recruiting NCT05162027 Phase 2 Erenumab-Aooe 70 MG in 1 mL Prefilled Syringe;Placebo
44 Neural Mechanisms of Immersive Virtual Reality in Chronic Pain Recruiting NCT04851301 Phase 1, Phase 2 Naloxone
45 Stem Cells Transplantation for Temporomandibular Joint Disease: Phase I/II Study Recruiting NCT05305833 Phase 1, Phase 2
46 Photobiomodulation for the Management of Temporomandibular Disorder Pain Active, not recruiting NCT04415281 Phase 2
47 Non-Invasive Intravascular Laser Irradiation Of Blood In The Treatment Of Children With Temporomandibular Disorders - Study Protocol For A Randomized, Controlled, Blind, Clinical Trial Not yet recruiting NCT05297604 Phase 2
48 Effects of Masseter Manual Therapy on Temporomandibular Dysfunction: A Pilot Study Unknown status NCT00870922 Phase 1
49 Clinical Study for the Evaluation of the Safety and Effectiveness of Autologous Chondrocytes Transplantation for the Treatment of Condylar Resorption Associated With Dentofacial Deformities Completed NCT03137914 Phase 1
50 Global Postural Reeducation and Static Stretching Exercises in the Treatment of Myogenic Temporomandibular Disorders. A Randomized Study Completed NCT00993577 Phase 1

Search NIH Clinical Center for Temporomandibular Joint Anomaly

Sources

Genetic Tests for Temporomandibular Joint Anomaly

About this section
Sources

Anatomical Context for Temporomandibular Joint Anomaly

About this section

Organs/tissues related to Temporomandibular Joint Anomaly:

MalaCards : Skeletal Muscle, Tongue, Brain, Placenta, Bone, Cortex, Thyroid
Sources

Publications for Temporomandibular Joint Anomaly

About this section

Articles related to Temporomandibular Joint Anomaly:

(show top 50) (show all 2000)
# Title Authors PMID Year
1
Estimation of Temporomandibular Joint Dysfunction in Oral Cancer Survivors. 62 41
36444581 2022
2
Promising minimally invasive treatment modalities for symptomatic temporomandibular joint disc displacement with reduction: a randomized controlled clinical trial. 41
36456937 2022
3
Development of a new category system for the profile morphology of temporomandibular disorders patients based on cephalograms using cluster analysis. 41
36466455 2022
4
Assessing potential functionality of catechol-O-methyltransferase (COMT) polymorphisms associated with pain sensitivity and temporomandibular joint disorders. 53 62
20336436 2010
5
Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. 53 62
17084978 2007
6
Increase in RANKL: OPG ratio in synovia of patients with temporomandibular joint disorder. 53 62
16798863 2006
7
Temporomandibular joint segmentation in MRI images using deep learning. 62
36368120 2022
8
Proinflammatory cytokines levels in patients with temporomandibular joint disorder undergoing arthroscopy. 62
34716857 2022
9
Mandibular Reconstruction Using Iliac Flap Based on Occlusion-Driven Workflow Transferred by Digital Surgical Guides. 62
36007546 2022
10
Effectiveness of Physiotherapy in the Treatment of Temporomandibular Joint Dysfunction and the Relationship with Cervical Spine. 62
36428529 2022
11
An Atypical Path of the Lingual Nerve in the Retromolar Region: Incidence in Oral Surgery. 62
34287645 2022
12
Diagnostic performance of magnetic resonance imaging for degenerative temporomandibular joint disease. 62
36288407 2022
13
Intraarticular injections of platelet rich plasma and plasma rich in growth factors with arthrocenthesis or arthroscopy in the treatment of temporomandibular joint disorders: A systematic review. 62
34906730 2022
14
A case of sialolithiasis that mimicked temporomandibular joint disorder. 62
35246358 2022
15
Comparative Evaluation and Correlation of Pain Pattern in Neck Musculature Observed in Mild, Moderate, and Severe Temporomandibular Joint Disorder Cases as Compared to Non-temporomandibular Joint Disorder Cases. 62
36381943 2022
16
The effect of intraarticular botulinum toxin-A injection on symptoms of temporomandibular joint disorder. 62
35523405 2022
17
Temporomandibular Joint Disorder and Airway in Class II Malocclusion: A Review. 62
36415434 2022
18
[Temporomandibular joint disorders: current concepts for conservative management]. 62
36200964 2022
19
Viscosupplementation in the upper and lower compartments of the temporomandibular joint checked by ultrasonography in an ex vivo and in vivo study. 62
36289252 2022
20
Graded exposure and orthopedic manual physical therapy for kinesiophobia and function in chronic temporomandibular dysfunction: A case report. 62
32552574 2022
21
Evaluation of the effect of T-Scan™ as an adjunct to stabilization splint in the treatment of temporomandibular joint disorders. 62
36094222 2022
22
Influence of different treatment procedures on the temporomandibular joint after mandibular setback in skeletal class III - A retrospective study. 62
35987801 2022
23
Evaluation of the relationship between temporomandibular joint disorders and tinnitus with computed tomography. 62
35724865 2022
24
Lateral Cephalometric Analytical Uses for Temporomandibular Joint Disorders: The Importance of Cervical Posture and Hyoid Position. 62
36078792 2022
25
Alternative Prosthodontic Therapies: A Multifaceted Approach. 62
36284813 2022
26
Comparison of symptoms, signs, gender, and magnetic resonance images of temporomandibular joint disorder patients. 62
36170015 2022
27
An online survey of pelvic congestion support group members regarding comorbid symptoms and syndromes. 62
35831253 2022
28
Oral Health Status and Multiple Sclerosis: Classic and Non-Classic Manifestations-Case Report. 62
36135218 2022
29
Current Trends in the Management of Temporomandibular Joint Dysfunction: A Review. 62
36277551 2022
30
Aetiology and management options for secondary referred otalgia: a systematic review and meta-analyses. 62
36163556 2022
31
An Investigation of temporomandibular pain, headache, and fatigue in relation with long-term mask use during the COVID-19 pandemic period. 62
36155108 2022
32
Low Sleep Satisfaction Is Related to High Disease Burden in Tinnitus. 62
36078720 2022
33
Vertical Ramus Osteotomy, Is It Still a Valid Tool in Orthognathic Surgery? 62
36011805 2022
34
Intermediate Cervical Plexus Block for Refractory Bilateral Facial Pain From a Whiplash Injury in 3 Patients: A Case Report. 62
35952333 2022
35
Can malocclusion provide clinicians with information for differential diagnosis of temporomandibular joint diseases?: A review. 62
35984194 2022
36
Correlation of arthroscopic findings with clinical-radiological signs and symptoms of temporomandibular joint dysfunction: retrospective study of 829 joints. 62
35115221 2022
37
Impact of sports on temporomandibular dysfunction: a comparison of competitive and recreational female athletes as well as female non-athletes. 62
35484356 2022
38
5-HT3/7 and GABAB receptors mediate inhibition of trigeminal nociception by dietary supplementation of grape seed extract. 62
33544064 2022
39
Correlation between the analysis of the dentoalveolar square and the photometric clinical diagnosis of smile. 62
35060372 2022
40
"Testosterone decreases temporomandibular joint nociception"- A systematic review of studies on animal models. 62
35461068 2022
41
Advantages of deep learning with convolutional neural network in detecting disc displacement of the temporomandibular joint in magnetic resonance imaging. 62
35790841 2022
42
Three-dimensional, biomimetic electrospun scaffolds reinforced with carbon nanotubes for temporomandibular joint disc regeneration. 62
35562008 2022
43
Signs and Symptoms of Temporomandibular Dysfunction and Radiographic Condylar Morphology in Patients with Idiopathic Condylar Resorption. 62
35893380 2022
44
Craniofacial structures, occlusal features, and TMD symptoms in juvenile idiopathic arthritis patients: a retrospective study. 62
35856467 2022
45
Surgical Guides and Prebent Titanium Improve the Planning for the Treatment of Dentofacial Deformities Secondary to Condylar Osteochondroma. 62
34873102 2022
46
Neuralgia and Atypical Facial, Ear, and Head Pain. 62
35680205 2022
47
Evaluating the Efficacy of the Occlusal Splint on the Muscle Activity with the Transducer in Patients with Temporomandibular Joint Dysfunction Syndrome. 62
35712418 2022
48
The consequences of living with a severe malocclusion: A review of the literature. 62
34488471 2022
49
Is temporomandibular joint involvement more frequent in patients with epilepsy? A clinical study. 62
35725662 2022
50
Mandibular Myofibroma and Severe Trismus: A Complex Case and Review of Complications. 62
35720205 2022
Sources

Variations for Temporomandibular Joint Anomaly

About this section
Sources

Expression for Temporomandibular Joint Anomaly

About this section
Search GEO for disease gene expression data for Temporomandibular Joint Anomaly.
Sources

Pathways for Temporomandibular Joint Anomaly

About this section

Pathways related to Temporomandibular Joint Anomaly according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Vitamin D receptor pathway 74
11.52 TNFSF11 TNFRSF11B
2
Clock-controlled autophagy in bone metabolism 74
11.06 TNFSF11 TNFRSF11B
3
Transcription_Role of VDR in regulation of genes involved in osteoporosis 22
10.61 TNFSF11 TNFRSF11B
4
Type I collagen synthesis in the context of osteogenesis imperfecta 74
10.14 TNFSF11 TNFRSF11B
Sources

GO Terms for Temporomandibular Joint Anomaly

About this section
Sources

Sources for Temporomandibular Joint Anomaly

About this section
2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....